Febuxostat equals allopurinol for gout prophylaxis

被引：0
|
作者：
不详
机构：
来源：
CLEVELAND CLINIC JOURNAL OF MEDICINE | 2006年 / 73卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：214 / 214
页数：1
相关论文
共 50 条
  • [31] Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis
    Jutkowitz, Eric
    Alarid-Escudero, Fernando
    Choi, Hyon K.
    Kuntz, Karen M.
    Jalal, Hawre
    PHARMACOECONOMICS, 2017, 35 (10) : 1073 - 1085
  • [32] Liver Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Hong, Seokchan
    Won, Jebum
    Kwon, Oh Chan
    Oh, Ji Sean
    Kim, Yong-Gil
    Lee, Chang Keun
    Yoo, Bin
    ARTHRITIS & RHEUMATOLOGY, 2018, 70
  • [33] Prioritizing Future Research on Allopurinol and Febuxostat for the Management of Gout: Value of Information Analysis
    Eric Jutkowitz
    Fernando Alarid-Escudero
    Hyon K. Choi
    Karen M. Kuntz
    Hawre Jalal
    PharmacoEconomics, 2017, 35 : 1073 - 1085
  • [34] Cardiovascular Risk in Gout Patients Cardiovascular Safety of Febuxostat or Allopurinol in Participants with Gout and Cardiovascular Comorbidities (CARES)
    Mueller-Wieland, D.
    Nitschmann, S.
    INTERNIST, 2018, 59 (11): : 1224 - 1228
  • [35] COMPARISON OF URATE-LOWERING EFFICACY AND SAFETY OF FEBUXOSTAT AND ALLOPURINOL IN GOUT PATIENTS
    Singh, Gajendera
    Kumar, Hemant
    Soni, Udit
    Tyagi, Shikhar
    Aggarwal, Kritika
    Verma, Kavita
    Kumar, Sumit
    HETEROCYCLIC LETTERS, 2016, 6 (01): : 133 - 147
  • [36] Hepatic Safety of Febuxostat Compared with Allopurinol in Gout Patients with Fatty Liver Disease
    Lee, Jung Sun
    Won, Jebum
    Kwon, Oh Chan
    Lee, Seung Soo
    Oh, Ji Seon
    Kim, Yong-Gil
    Lee, Chang-Keun
    Yoo, Bin
    Hong, Seokchan
    JOURNAL OF RHEUMATOLOGY, 2019, 46 (05) : 527 - 531
  • [37] Febuxostat compared with allopurinol in patients with hyperuricemia and gout. Results of the FACT study
    不详
    KARDIOLOGIYA, 2006, 46 (07) : 79 - 79
  • [38] Sex difference in heart failure risk associated with febuxostat and allopurinol in gout patients
    Cheng, Ching-Lan
    Yen, Chi-Tai
    Su, Chien-Chou
    Lee, Cheng-Han
    Huang, Chien-Huei
    Yang, Yea-Huei Kao
    FRONTIERS IN CARDIOVASCULAR MEDICINE, 2022, 9
  • [39] Safety and Efficacy of Febuxostat Treatment in Subjects with Gout and Severe Allopurinol Adverse Reactions
    Chohan, Saima
    JOURNAL OF RHEUMATOLOGY, 2011, 38 (09) : 1957 - 1959
  • [40] Febuxostat versus allopurinol in the treatment of gout in subjects 65 years of age or older
    Schumacher, H. R.
    Becker, M. A.
    MacDonald, P. A.
    Lloyd, E. J.
    Lademacher, C.
    Joseph-Ridge, N.
    ANNALS OF THE RHEUMATIC DISEASES, 2007, 66 : 234 - 235
12345